EPISKIN is a tissue engineering company that provides Reconstructed Human Tissues to the global scientific community, encompassing both academia and industry, to bolster research and development in safety and efficacy. Based in Lyon, France, EPISKIN collaborates with the cosmetic, pharmaceutical, and chemical sectors to forge relevant and reliable safety and efficacy assessments. Their cell culture technique enables the mass production of in vitro models of reconstructed human tissues, distinguished by their well-defined histology, functionality, and ultrastructure. Their offerings include Reconstructed Human Epidermis; Reconstructed Human Epidermis with Melanocytes available in various complexions from phototype II to VI; Full Thickness Model combining dermis and epidermis; Reconstructed Human Corneal Epithelium; and Reconstructed Human Mucosa for Oral, Gingival, and Vaginal Epithelium. These models facilitate the evaluation of raw materials, active ingredients, and final products, whether they are solid, liquid, powder, cream, or gel.